Day: April 22, 2025

SEATTLE, April 22, 2025 (GLOBE NEWSWIRE) — Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”), a clinical-stage biopharmaceutical company developing innovative medicines for breast cancer, today announced that the United States Patent and Trademark Office (USPTO) has granted a new patent (U.S. Patent No. 12,275,684) directed to enteric oral formulations comprising (Z)-endoxifen as well as methods of treating subjects with those oral formulations. This newly granted patent further fortifies Atossa’s intellectual property portfolio surrounding its proprietary (Z)-endoxifen formulations, encompassing novel compositions and methods related to (Z)-endoxifen, a potent Selective Estrogen Receptor Modulator (SERM). Specifically, the patent covers enteric oral formulations of (Z)-endoxifen and salts thereof as well as...

In a survey representative of the general U.S. adult population, 1.26 percent of respondents – equivalent to about 3 million people – reported having received a medical diagnosis of babesiosis during their life-time; CDC data imply only about 73,000 people in that category. At the time they replied to the survey, 3.7 percent of respondents – equivalent to about 9.9 million people – reported they had been experiencing fatigue, a common symptom of babesiosis, for six months or longer.WASHINGTON, April 22, 2025 (GLOBE NEWSWIRE) — 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (“60 Degrees” or the “Company”), a pharmaceutical company focused on developing new medicines for infectious diseases, today announced findings that the actual burden of babesiosis in the United States (U.S.) may be significantly higher than Centers...

CHICAGO, April 22, 2025 (GLOBE NEWSWIRE) — GCM Grosvenor (Nasdaq: GCMG), a leading global alternative asset management solutions provider, announced the final close of its Infrastructure Advantage Fund II (“IAF II” or the “Fund”) was held on March 31, 2025, securing $1.3 billion in commitments, a substantial increase over its predecessor, “Fund I”, which closed in 2020 at $893 million.    GCM Grosvenor’s Infrastructure Advantage Strategy focuses on partnership with organized labor and other stakeholders to invest in infrastructure projects with long-term community and economic benefits. Similar to Fund I, IAF II will focus on building a diverse portfolio of assets across infrastructure sectors including transportation, energy transition, and digital infrastructure. The Fund attracted a broad group of 58 investors...

A Scientific Breakthrough in Skin Renewal: A Clinically Proven Dual-Action, Slow-Release, Overnight Skin Renewal Cream for a Resurfaced, Smoother, and More Even-Looking ComplexionNEW YORK, April 22, 2025 (GLOBE NEWSWIRE) — Obagi Medical (“Obagi”), the fastest-growing professional skincare brand in the U.S. in 2024* and a subsidiary of Waldencast plc, (NASDAQ: WALD) (“Waldencast”), proudly introduces its latest breakthrough: Retinol + PHA Refining Night Cream. This advanced formulation is engineered to optimize skin renewal by leveraging the efficacy of Entrapped Retinol with the scientifically proven gentle exfoliating properties of Polyhydroxy Acid (PHA) Gluconolactone. This synergistic combination enhances cell turnover while reinforcing the skin barrier, resulting in a visibly refined, smoother, and more even...

BAYONNE, N.J., April 22, 2025 (GLOBE NEWSWIRE) — BCB Bancorp, Inc. (the “Company”), (NASDAQ: BCBP), the holding company for BCB Community Bank (the “Bank”), today reported a net loss of $8.3 million for the first quarter of 2025, compared to net income of $3.3 million in the fourth quarter of 2024, and net income of $5.9 million for the first quarter of 2024. Its loss per diluted share for the first quarter of 2025 was ($0.51), compared to earnings per diluted share of $0.16 in the preceding quarter and $0.32 in the first quarter of 2024. The Company also announced that its Board of Directors declared a regular quarterly cash dividend of $0.16 per share. The dividend will be payable on May 21, 2025 to common shareholders of record on May 7, 2025. “Our first-quarter loss was primarily driven by a $13.7 million specific reserve tied...

AUSTIN, Texas, April 22, 2025 (GLOBE NEWSWIRE) — EZCORP, Inc. (“EZCORP” or the “Company”) (NASDAQ: EZPW), a leading provider of pawn transactions in the United States and Latin America, will issue second quarter fiscal 2025 results (period ended March 31, 2025) on Monday, April 28, 2025, after the market close. The Company will host a webcast and conference call at 9:00 a.m. Eastern time on Tuesday, April 29, 2025, to discuss its results. The presentation slides will be posted to the Investor Relations section of its website after the market close on Monday, April 28, 2025. Date: Tuesday, April 29, 2025Time: 9:00 a.m. Eastern timeDial-in registration link: https://registrations.events/direct/NTM1088399 Live webcast registration link: https://edge.media-server.com/mmc/p/hqptihjy A replay of the conference call will be available...

Conference attendees will get first look at new data that supports the potential of ERNA-101 to boost anti-tumor immunity in ovarian cancer CAMBRIDGE, Mass., April 22, 2025 (GLOBE NEWSWIRE) — Ernexa Therapeutics (Nasdaq: ERNA), developing innovative cell therapies for the treatment of advanced cancer and autoimmune disease, today announced that new data will be presented at the American Association for Cancer Research (AACR) Annual Meeting 2025 in Chicago. The study explored the technology behind Ernexa’s lead cell therapy product, ERNA-101, which uses specially engineered cells to deliver treatment directly to ovarian tumors. By secreting immune-stimulating cytokines, this cell therapy treatment aims to reshape the tumor microenvironment and enhance anti-tumor immune responses, fighting off the cancer. The study was led by Michael...

WILMINGTON, Mass., April 22, 2025 (GLOBE NEWSWIRE) — Liberty Defense Holdings Ltd. (“Liberty” or the “Company”) (TSXV: SCAN, OTCQB: LDDFF, FSE:E30) a leading technology provider of AI-based next generation security detection solutions for concealed weapons and threats, is pleased to announce that the Honorable James Byrne, former Deputy Secretary of Veterans Affairs and current Vice President, Ethics & Business Conduct, for Lockheed Martin, has joined our new Strategic Advisory Board which will have up to nine Members. This new Board will help focus and guide Liberty Defense in its journey to scale its groundbreaking technology, both in the United States and globally. A retired United States Marine Corps infantry officer and federal prosecutor, Mr. Byrne served as Deputy Secretary and General Counsel of the United States Department...

CAMARILLO, Calif., April 22, 2025 (GLOBE NEWSWIRE) — Salem Media Group, Inc. (OTCQX: SALM) is proud to announce a powerful new addition to its growing lineup of fearless voices. Nationally syndicated talk radio host Joe Pags is launching a new podcast, “Unshaken and Unafraid.” exclusively with Salem. Joe will be doing three episodes per week. This show marks a new chapter for one of conservative media’s boldest voices. It’s a significant step forward in Salem Media’s mission to deliver trusted conservative content across radio, television, podcasts, and streaming. Joe Pags has interviewed hundreds of high-profile figures, including multiple exclusive conversations with President Donald J. Trump. He’s earned a reputation as a relentless truth-teller and no-nonsense commentator. But his impact has gone far beyond the mic. They tried...

Rigetti, in collaboration with Riverlane and the National Quantum Computing Centre (NQCC), has been selected as one of the winners of Innovate UK’s Quantum Missions pilot competition. Leveraging Rigetti’s quantum computer hosted at the NQCC, the £3.5 million Rigetti-led consortium aims to benchmark and enhance the quantum error correction capabilities of superconducting quantum computers — a requirement for achieving large-scale fault-tolerant quantum computing. BERKELEY, Calif., April 22, 2025 (GLOBE NEWSWIRE) — Rigetti UK Limited, a wholly owned subsidiary of Rigetti Computing, Inc. (Nasdaq: RGTI) (“Rigetti” or the “Company”), a pioneer in full-stack quantum-classical computing, today announced that it has been selected as one of the winners of Innovate UK’s Quantum Missions pilot competition to benchmark and enhance quantum...